Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from ImExHS Limited ( (AU:IME) ) is now available.
ImExHS Limited has announced a change in the director’s interest, specifically involving Douglas Flynn. The change includes the acquisition and disposal of various securities, with Flynn acquiring 74,711 nil price options and additional fully paid ordinary shares through off-market transfers and conditional placements. This adjustment in Flynn’s holdings reflects strategic moves within the company’s governance and could potentially impact its market positioning and stakeholder interests.
The most recent analyst rating on (AU:IME) stock is a Buy with a A$1.15 price target. To see the full list of analyst forecasts on ImExHS Limited stock, see the AU:IME Stock Forecast page.
More about ImExHS Limited
ImExHS Limited operates in the medical imaging industry, providing innovative healthcare solutions through its advanced imaging software and services. The company focuses on delivering efficient and scalable imaging solutions to healthcare providers, enhancing diagnostic capabilities and patient care.
Average Trading Volume: 23,833
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$18.24M
See more data about IME stock on TipRanks’ Stock Analysis page.